Wassim Almawi
From Wikipedia, the free encyclopedia
 |
This biographical article or section is written like a résumé. Please help improve this article by revising it to be neutral and encyclopedic. (help) |
Wassim Y. Almawi is currently Associate Professor of Medical Biochemistry and Medicine, and Chief of Special and Molecular Diagnostics Laboratory, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain. He graduated in Biology-Chemistry (B.Sc.) from Beirut University College in 1980, and Pharmacology (M.Sc. and Ph.D.) from Dalhousie University, Halifax, Canada. After obtaining the Ph.D. in 1987, he spent 4 years as a post-doctoral fellow at Universite' de Sherbrooke, University of British Columbia (Vancouver, Canada), and Harvard Medical School (Boston, USA), funded by Fonds de la Recherche en Sante' du Quebec (FRSQ) and Kidney Foundation of Canada (KFOC).
He was appointed Assistant Professor of Pharmacology and Medicine at the University of Western Ontario and Scientist (Immunology Group) at the Robarts Research Institute in 1991. Dr. Almawi actively participated in the Multi-Organ Transplant Service (MOTS) at University Hospital (London, Canada), and obtained peer-reviewed personal and research support from local, national and international granting agencies. He was appointed as Assistant Professor of Biochemistry at [[]American University of Beirut]] (1993-1997), lecturer at Haigazian University (1998-present) and University of Balamand (1997-2000), and is currently appointed as Associate Professor of Medical Biochemistry and Medicine, Gulf University (2000-present).
Dr. Almawi has published in excess of 20 peer-reviewed manuscripts over a six-year period in Beirut, and in excess of 58 original papers over a 5-year period in Bahrain. In addition to academia, he was appointed as Chief of Molecular Biology and Transplantation Immunology at St. Georges-Orthodox Hospital in Beirut (1997-2000), and Chief of the Special and Molecular Diagnostics Laboratory in Bahrain (2000-present). Most recently, appointed as Senior Scientist, Al-Jawhara Center for Molecular Medicine, Gulf University, Manama, Bahrain.
Awarded the first clinical scholarship to a non-physician from the Kidney Foundation of Canada - Nephrology Scholarship - in 1991, and the first Alpha Omega Alpha grant to AUB in 1996. Current research interests focuse on mode of action of corticosteroids, altered T cell immunity in type 1 (insulin-dependent) diabetes, genetics of type 2 diabetes, and inherited risk factors of venous thrombosis. Dr. Almawi delivered numerous invited lectures at international meetings including American Society of Transplant Physicians, Joint AAI/CIS Meeting, and International Congress of Immunology. He is also an active member of a number of scientific societies, including American Society of Nephrology, American Society of Transplant Physicians, Clinical Immunology Society, and Society for Leukocyte Biology. He is a reviewer of research grant applications to Lebanese National Council of Scientific Research, Medical Research Council of Canada, and Kidney Foundation of Canada.
